CLINICAL_TRIALS
trial_result
· 2013-01-08
Clinical Trial Update: Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients [Phase 2]
Summary
This clinical trial update reports results from a Phase 2 study evaluating a 2-hour infusion of ON 01910.Na in patients with ovarian cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Traws Pharma, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-01-08